This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Ibuprofen API Market

Market Insights on Ibuprofen API covering sales outlook, demand forecast & up-to-date key trends

Ibuprofen API Market by End User & Region - Forecast 2022 - 2029

Ibuprofen API Market Outlook (2022-2029)

[170 Pages Report] Newly released data on the ibuprofen API market analysis shows that global demand for ibuprofen APIs is currently valued at around US$ 626.2 Mn, and is anticipated to increase at a CAGR of 3% to reach US$ 772.2 Mn by 2029.

Ibuprofen API Market Size (2022)

US$ 626.2 Mn

Revenue Forecast (2029)

US$ 772.2 Mn

Global Market Growth Rate (2022-2029)

3% CAGR

Pharmaceutical Companies’ Market Share

55.4%

The market is expanding due to an increase in pharmaceutical and biopharmaceutical production, as well as the rising prevalence of chronic diseases across the world. Ibuprofen API revenue currently accounts for 0.8% share in the global analgesics market.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

3.03%

H1, 2022 Projected

3.04%

H1, 2022 Outlook

2.84%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 20 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 19 ↓

H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 20 BPS. However, In H1-2022, the growth rate of ibuprofen API market is expected to fall by 19 basis point share (BPS), as per FMI analysis.

The dip in the BPS values is associated with drawbacks of synthesis of ibuprofen API, which poses environmentally restrictive impact. As considerations for sustainable manufacturing are accelerating, revised production guidelines have posed a negative impact upon manufacturers in terms of cost and raw material sourcing within the market.

There have been established, several methods for development of a synthetic route to ibuprofen. This factor is expected to push the overall market growth for ibuprofen API manufacturing, thus presenting a positive sales outlook.

The key developments in the market include advanced synthesis routes for NSAID skeletons, which will promote the production of ibuprofen API. Moreover, with OTC sales of the drug, the market will present a strong growth outlook during the forecast years.

Ibuprofen API Demand Analysis (2014 to 2021) Vs Market Outlook (2022 to 2029)

APIs (active pharmaceutical ingredients) are bulk medicinal products used as basic materials in pharmaceutical formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that includes medications that act as analgesics (pain relievers) and antipyretics (fever reducers), as well as anti-inflammatory actions in higher doses.

Ibuprofen is a type of NSAID used to relieve pain, swelling, and fever. This treatment can also be used to close a patent ductus arteriosus in a premature newborn. It can be taken orally or intravenously, and it usually takes an hour to work.

The ibuprofen active pharmaceutical ingredient market expanded at a CAGR of 2.9% from 2014 to 2021. The worldwide incidence of a wide range of illnesses, particularly heart disorders, contagious infections, diabetes, and kidney-related problems, is considerable. As a result, the rising frequency of a wide range of illnesses among all age groups, as well as their global burden, drives drug development and market growth.

For effective drug candidate identification, improved technologies such as bioinformatics, high throughput, and combinatorial chemistry are being used more frequently. Technological innovations have considerably aided drug discovery, allowing the method to become more precise, effective, and time-efficient.

High-throughput screening is among the most extensively utilized drug discovery tools, multi-detector readers, due to automation, imaging hardware, and software.

Sales of ibuprofen APIs are predicted to progress at a CAGR of 3% from 2022 to 2029, with the global market expected to reach a valuation of US$ 772.2 Mn by 2029.

Ibuprofen API Market Download Report Brochure

Which Factors Create Opportunities for Ibuprofen API Market Players to Generate High Revenue?

“Ibuprofen APIs Boon for Women Healthcare Due to Effective Results”

Ibuprofen's use in maternal care has opened up new growth potential for the worldwide ibuprofen API market. The popularity of ibuprofen stems from its ability to relieve pain in people with arthritis and menstruation discomfort.

The medical community has been vocal about promoting the use of ibuprofen API in hospitals and other healthcare settings. In addition, the potential of ibuprofen to close a specific ductus in newborn newborns has fueled global ibuprofen API market growth.

“Effective and Efficient Results of Ibuprofen APIs for Body Pain”

The healthcare business has begun to focus on ancillary treatment lines for body aches and pains. Several GPs throughout the world recommend that patients use ibuprofen API as their first line of treatment.

Furthermore, the quick and successful treatment mechanism of ibuprofen has given the medical community confidence in recommending it. Furthermore, developments in medical treatments and pain control research lines will propel market growth.

“Arthritis Dominates Global Ibuprofen API Market Share”

In simple words, the pain of a joint is referred to as arthritis. Stiffness, warmth, swelling, redness, and discomfort are all symptoms of inflamed joints.

Over 100 different forms of arthritis exist, including rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, lupus, gout, psoriatic arthritis, pseudogout, and others. Rheumatoid arthritis is an autoimmune disease that causes inflammation and pain in the body's joints.

Joints in the body are most commonly affected by rheumatoid arthritis. In the treatment of rheumatoid arthritis, ibuprofen is just as effective as aspirin and other NSAIDs. Ibuprofen's tolerability and safety are superior to aspirin's, and it compares favorably to other NSAIDs.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What May Dent Sales Growth of Ibuprofen APIs?

“Unstable Supply of Required Components & Rising Raw Material Cost May Impede Sales of Ibuprofen APIs”

Constraints such as the unreliable supply of essential components and rising raw material prices (Isobutyl Benzene) are anticipated to stifle the ibuprofen API market's expansion.

Manufacturers are under pricing pressure, which limits their ability to innovate in manufacturing procedures. As a result, the market lacks behind completely accepting tech-enabled changes.

Which Ibuprofen API Regional Market is Generating Most Revenue?

“Availability of Labour at Low Cost, Abundance of Raw Materials, and Benefits in Taxation Attract Ibuprofen API Manufactures to Asia Pacific”

North America would remain the core of investment potential in the ibuprofen API market, owing to the strong footholds of top manufacturers and high use of nonsteroidal anti-inflammatory drugs. High demand and advancements in production technology boost the sales growth of the Europe ibuprofen active pharmaceutical ingredient market.

However, in the coming years, Asia Pacific is likely to provide even more prospects for growth and profit. The region's market expansion is mostly due to the availability of low-cost labour and sufficient raw materials required to manufacture ibuprofen active pharmaceutical ingredients.

Stakeholders are also being attracted by a favorable regulatory environment for establishing industrial facilities, as well as stable taxation laws. Furthermore, the majority of antibiotics and anti-inflammatory medications are produced in Asia, with China and India accounting for roughly more than 60% of the total share.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Analysis

How is Demand for Ibuprofen APIs Shaping Up in India?

“Rising Cases of Rheumatoid Arthritis Driving Sales of Ibuprofen APIs”

Rheumatoid arthritis impacts around 1 percent of the population in India. As a result, around 1 million people are estimated to be affected by this kind of arthritis.

Most people believe that arthritis is a disease that only affects the elderly and that the younger generation is immune to it. Arthritis, on the other hand, can affect people of all ages.

India is the world's third-largest volume manufacturer of pharmaceuticals. India's low manufacturing costs have increased production facilities, attracting biotechnology and pharmaceutical companies.

As a result, increasing spending on healthcare infrastructure, the availability of raw materials, and secure taxation regulations all contribute to the growth of the ibuprofen active pharmaceutical ingredient market.

How is the U.S. Ibuprofen API Market Progressing?

“Rising Incidence of Migraine Fueling Demand for Ibuprofen APIs”

The U.S. dominates North America ibuprofen API market. The U.S. ibuprofen API market is expected to expand at a healthy growth rate over the forecast period.

This is due to rising occurrence of migraine and other similar conditions in the country, which can be related to a stressful lifestyle, changing environment, increased pollution, and biological heredity. 

In the adult population of the United States, the incidence and burden of self-reported migraine and severe headache is considerable. Migraines affect a large portion of the population in the country, which is fuelling market expansion.

The population of the country is also afflicted with a variety of cardiovascular and chronic diseases, which also boosts market growth.

Category-wise Analysis

Which End User is Driving High Ibuprofen API Market Growth?

“High Investments in R&D of Ibuprofen APIs Boosts Sales Growth of Pharmaceutical Companies”

Contract manufacturing organisations (CMOs) are rethinking their strategy to keep up with the changing dynamics of the pharmaceutical sector, which include cost-cutting and better differentiation from competitors. Contract manufacturing organisations are heavily preferred by major pharmaceutical companies to manufacture APIs and final formulations.

Contract manufacturing organisations are increasingly being integrated into pharmaceutical businesses' supply chains. CMOs are also partnering with other CMOs to provide bundled services.

In 2022, CMOs are likely to hold 44.6% of the global market share, while pharmaceutical companies are expected to account for 55.4% share.

To stay ahead of the international competition, pharmaceutical companies are raising production prices and investing extensively in R&D activities. Ibuprofen is a nonsteroidal anti-inflammatory drug with a lot of demand and the opportunity to generate high profit.

Furthermore, the presence of a wide range of disorders is driving ibuprofen active pharmaceutical ingredient demand, resulting in increased sales of pharmaceutical companies.

Competitive Landscape

Various ibuprofen API suppliers are focusing on mergers and acquisitions with CMOs to establish their proprietary pharmaceutical intermediate and small molecule API units to improve raw material supply and keep up with the pace of final formulation manufacturing.

The number of mergers in the pharma API sector has increased in recent years, intending to meet therapeutic, pipeline, and global expansion objectives. Mergers and acquisitions thus play a significant role in the majority of pharmaceutical companies’ growth strategies in the ibuprofen API industry, as they save time and money.

  • BASF SE is trying to expand its manufacturing capabilities in Germany and the United States. By 2023, the company intends to have increased its capacity by more than 30%.

BASF SE, BIOCAUSE Inc., IOL Chemicals And Pharmaceuticals Limited, SI Group, Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd., and Solara Active Pharma Sciences Limited are key market players included in this report.

Ibuprofen API Industry Report Scope

Attribute

Details

Forecast Period       

2022-2029

Historical Data Available for

2014-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • End User
  • Region

Key Companies Profiled

  • BASF SE
  • BIOCAUSE Inc.
  • IOL Chemicals And Pharmaceuticals Limited
  • SI Group, Inc.
  • Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd.
  • Solara Active Pharma Sciences Limited
  • Granules India Limited

Pricing

Available upon Request

Key Segments of Ibuprofen API Industry Survey

Ibuprofen API Market by End User:

  • Contract Manufacturing Organizations
  • Pharmaceutical Companies

Ibuprofen API Market by Region:

  • North America Ibuprofen API Market
  • Latin America Ibuprofen API Market
  • Europe Ibuprofen API Market
  • East Asia Ibuprofen API Market
  • South Asia & Pacific Ibuprofen API Market
  • Middle East & Africa (MEA) Ibuprofen API Market

Frequently Asked Questions

The ibuprofen API market has been studied from 2014 to 2029.

The global ibuprofen API market is estimated to progress at a CAGR of 3% from 2022 to 2029.

The global ibuprofen API market is currently valued at around US$ 626.2 Mn, and is estimated to reach US$ 772.2 Mn by 2030.

The Asia Pacific ibuprofen API regional market is expected to expand at a high CAGR over the forecast period.

Key market players profiled in this report are BASF SE, BIOCAUSE Inc., IOL Chemicals And Pharmaceuticals Limited, SI Group, Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd., Solara Active Pharma Sciences Limited, and Granules India Limited.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Trends

    1.3. Technology Roadmap

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

    3.3. Strategic Promotional Strategies, By Key Manufacturers

4. Market Context

    4.1. Product USPs/ Features

    4.2. Region wise Consumption

    4.3. Regulatory Scenario

5. Global Ibuprofen API Market Volume (TPA) Analysis 2014-2021 and Forecast, 2022-2029

    5.1. Historical Market Volume (TPA) Analysis, 2014-2021

    5.2. Current and Future Market Volume (TPA) Projections, 2022-2029

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Opportunity Analysis, 2022-2029

6. Market Background

    6.1. Macro-Economic Factors

        6.1.1. Global GDP Growth Outlook

        6.1.2. Global Healthcare Outlook

    6.2. Forecast Factors - Relevance & Impact

        6.2.1. Research and Developmental Activities

        6.2.2. Technological Advancement

        6.2.3. Adoption of Ibuprofen API

        6.2.4. Cost of production

        6.2.5. Supply chain 

        6.2.6. Focus of Manufacturer to increase capacity

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunities 

7. Global Ibuprofen API Market Value (US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029

    7.1. Historical Market Value (US$ Mn) Analysis, 2014-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Opportunity Analysis, 2022-2029

8. Global Ibuprofen API Market Analysis 2014-2021 and Forecast 2022-2029, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By End User, 2014-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2029

        8.3.1. Contract Manufacturing Organization

        8.3.2. Pharmaceutical Companies

    8.4. Market Attractiveness Analysis By End User

9. Global Ibuprofen API Market Analysis 2014-2021 and Forecast 2022-2029, by Region

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2029

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia

        9.3.6. Oceania

        9.3.7. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Ibuprofen API Market Analysis 2014-2021 and Forecast 2022-2029

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2029

        10.3.1. By Country

            10.3.1.1. U.S.

            10.3.1.2. Canada

        10.3.2. By End User

    10.4. Market Attractiveness Analysis

    10.5. Drivers and Restraints - Impact Analysis

11. Latin America Ibuprofen API Market Analysis 2014-2021 and Forecast 2022-2029

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2029

        11.3.1. By Country

            11.3.1.1. Brazil

            11.3.1.2. Mexico

            11.3.1.3. Argentina

            11.3.1.4. Rest of Latin America

        11.3.2. By End User

    11.4. Market Attractiveness Analysis

    11.5. Drivers and Restraints - Impact Analysis

12. Europe Ibuprofen API Market Analysis 2014-2021 and Forecast 2022-2029

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2029

        12.3.1. By Country

            12.3.1.1. Germany

            12.3.1.2. Italy

            12.3.1.3. France

            12.3.1.4. U.K.

            12.3.1.5. Spain

            12.3.1.6. BENELUX

            12.3.1.7. Russia

            12.3.1.8. Rest of Europe

        12.3.2. By End User

    12.4. Market Attractiveness Analysis

    12.5. Drivers and Restraints - Impact Analysis

13. South Asia Ibuprofen API Market Analysis 2014-2021 and Forecast 2022-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2029

        13.3.1. By Country

            13.3.1.1. India

            13.3.1.2. Thailand

            13.3.1.3. Malaysia

            13.3.1.4. Rest of South Asia

        13.3.2. By End User

    13.4. Market Attractiveness Analysis

    13.5. Drivers and Restraints - Impact Analysis

14. East Asia Ibuprofen API Market Analysis 2014-2021 and Forecast 2022-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2029

        14.3.1. By Country

            14.3.1.1. China

            14.3.1.2. Japan

            14.3.1.3. South Korea

        14.3.2. By End User

    14.4. Market Attractiveness Analysis

    14.5. Drivers and Restraints - Impact Analysis

15. Oceania Ibuprofen API Market Analysis 2014-2021 and Forecast 2022-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2029

        15.3.1. By Country

            15.3.1.1. Australia

            15.3.1.2. New Zealand

        15.3.2. By End User

    15.4. Market Attractiveness Analysis

    15.5. Drivers and Restraints - Impact Analysis

16. Middle East and Africa Ibuprofen API Market Analysis 2014-2021 and Forecast 2022-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2029

        16.3.1. By Country

            16.3.1.1. GCC Countries

            16.3.1.2. South Africa

            16.3.1.3. Rest of Middle East and Africa

        16.3.2. By End User

    16.4. Market Attractiveness Analysis

    16.5. Drivers and Restraints - Impact Analysis

17. Emerging Countries Ibuprofen API Market Analysis 2014-2021 and Forecast, 2022-2029

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. China Ibuprofen API Market Analysis

        17.2.1. Introduction

        17.2.2. PEST Analysis

        17.2.3. Market Value Proportion Analysis by Market Taxonomy

        17.2.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            17.2.4.1. By End User

    17.3. India Ibuprofen API Market Analysis

        17.3.1. Introduction

        17.3.2. PEST Analysis

        17.3.3. Market Value Proportion Analysis by Market Taxonomy

        17.3.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            17.3.4.1. By End User

    17.4. Brazil Ibuprofen API Market Analysis

        17.4.1. Introduction

        17.4.2. PEST Analysis

        17.4.3. Market Value Proportion Analysis by Market Taxonomy

        17.4.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            17.4.4.1. By End User

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies 

    18.2. Market Share Analysis of Top Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive (Tentative List*)

        19.3.1. SI Group, Inc.

            19.3.1.1. Overview

            19.3.1.2. Product  Portfolio

            19.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.1.4. Sales Footprint

            19.3.1.5. Strategy Overview

                19.3.1.5.1. Marketing Strategy

                19.3.1.5.2. Product Strategy

                19.3.1.5.3. Channel Strategy

        19.3.2. BASF SE

            19.3.2.1. Overview

            19.3.2.2. Product  Portfolio

            19.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.2.4. Sales Footprint

            19.3.2.5. Strategy Overview

                19.3.2.5.1. Marketing Strategy

                19.3.2.5.2. Product Strategy

                19.3.2.5.3. Channel Strategy

        19.3.3. Hubei Biocause Phamaceutical Co., Ltd. (BIOCAUSE Inc.)

            19.3.3.1. Overview

            19.3.3.2. Product  Portfolio

            19.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.3.4. Sales Footprint

            19.3.3.5. Strategy Overview

                19.3.3.5.1. Marketing Strategy

                19.3.3.5.2. Product Strategy

                19.3.3.5.3. Channel Strategy

        19.3.4. IOL Chemicals

            19.3.4.1. Overview

            19.3.4.2. Product  Portfolio

            19.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.4.4. Sales Footprint

            19.3.4.5. Strategy Overview

                19.3.4.5.1. Marketing Strategy

                19.3.4.5.2. Product Strategy

                19.3.4.5.3. Channel Strategy

        19.3.5. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd.

            19.3.5.1. Overview

            19.3.5.2. Product  Portfolio

            19.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.5.4. Sales Footprint

            19.3.5.5. Strategy Overview

                19.3.5.5.1. Marketing Strategy

                19.3.5.5.2. Product Strategy

                19.3.5.5.3. Channel Strategy

        19.3.6. Solara Active Pharma Sciences Limited.

            19.3.6.1. Overview

            19.3.6.2. Product  Portfolio

            19.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.6.4. Sales Footprint

            19.3.6.5. Strategy Overview

                19.3.6.5.1. Marketing Strategy

                19.3.6.5.2. Product Strategy

                19.3.6.5.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 03: Global Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 04: Global Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Region

Table 05: Global Ibuprofen API Market Volume (TPA) Analysis 2014-2021 and Forecast 2022-2029, By Region

Table 06: North America Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 07: North America Ibuprofen API Market Volume (TPA) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 08: North America Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 09: Latin America Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 10: Latin America Ibuprofen API Market Volume (TPA) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 11: Latin America Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 12: Europe Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 13: Europe Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 14: Europe Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 15: South Asia Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 16: South Asia Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 17: South Asia Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 18: East Asia Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 19: East Asia Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 20: East Asia Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 21: Oceania Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 22: Oceania Ibuprofen API Market Volume (TPA) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 23: Oceania Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 24: MEA Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 25: MEA Ibuprofen API Market Volume (TPA) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 26: MEA Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 27: China Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 28: India Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 29: Brazil Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Ibuprofen API Market Share, By End User (2021)

Figure 02: Global Ibuprofen API Market Share, By Region (2021)

Figure 03: Global Healthcare Expenditure in US$ Tn (2013-2020)

Figure 04: Global Ibuprofen API Historical Market Size and Y-o-Y, 2014-2021

Figure 05: Global Ibuprofen API Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2029

Figure 06: Global Ibuprofen API Market Absolute $ Opportunity, 2014-2029

Figure 07: Global Ibuprofen API Market Analysis by End User -2022 & 2029

Figure 08: Global Ibuprofen API Market Y-o-Y Growth Projections by End User, 2022 - 2029

Figure 09: Global Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Figure 10: Global Ibuprofen API Market Analysis by Region -2022 & 2029

Figure 11: Global Ibuprofen API Market Y-o-Y Growth Projections by Region, 2022 - 2029

Figure 12: Global Ibuprofen API Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Region

Figure 13: North America Ibuprofen API Market Size (US$ Mn) Analysis, 2014-2021

Figure 14: North America Ibuprofen API Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 - 2029

Figure 15: North America Ibuprofen API Market Analysis by Country -2022 & 2029

Figure 16: North America Ibuprofen API Market Y-o-Y Growth Projections by Country, 2022 - 2029

Figure 17: North America Ibuprofen API Market Attractiveness Analysis by Country, 2022 - 2029

Figure 18: North America Ibuprofen API Market Analysis by End User - 2022 & 2029

Figure 19: North America Ibuprofen API Market Y-o-Y Growth Projections by End User, 2022 - 2029

Figure 20: North America Ibuprofen API Market Attractiveness Analysis by End User, 2022 - 2029

Figure 21: Latin America Ibuprofen API Market Size (US$ Mn) Analysis, 2014-2021

Figure 22: Latin America Ibuprofen API Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 - 2029

Figure 23: Latin America Ibuprofen API Market Analysis by Country -2022 & 2029

Figure 24: Latin America Ibuprofen API Market Y-o-Y Growth Projections by Country, 2022 - 2029

Figure 25: Latin America Ibuprofen API Market Attractiveness Analysis by Country, 2022 - 2029

Figure 26: Latin America Ibuprofen API Market Analysis by End User - 2022 & 2029

Figure 27: Latin America Ibuprofen API Market Y-o-Y Growth Projections by End User, 2022 - 2029

Figure 28: Latin America Ibuprofen API Market Attractiveness Analysis by End User, 2022 - 2029

Figure 29: Europe Ibuprofen API Market Size (US$ Mn) Analysis, 2014-2021

Figure 30: Europe Ibuprofen API Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 - 2029

Figure 31: Europe Ibuprofen API Market Analysis by Country -2022 & 2029

Figure 32: Europe Ibuprofen API Market Y-o-Y Growth Projections by Country, 2022 - 2029

Figure 33: Europe Ibuprofen API Market Attractiveness Analysis by Country, 2022 - 2029

Figure 34: Europe Ibuprofen API Market Analysis by End User - 2022 & 2029

Figure 35: Europe Ibuprofen API Market Y-o-Y Growth Projections by End User, 2022 - 2029

Figure 36: Europe Ibuprofen API Market Attractiveness Analysis by End User, 2022 - 2029

Figure 37: South Asia Ibuprofen API Market Size (US$ Mn) Analysis, 2014-2021

Figure 38: South Asia Ibuprofen API Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 - 2029

Figure 39: South Asia Ibuprofen API Market Analysis by Country - 2022 & 2029

Figure 40: South Asia Ibuprofen API Market Y-o-Y Growth Projections by Country, 2022 - 2029

Figure 41: South Asia Ibuprofen API Market Attractiveness Analysis by Country, 2022 - 2029

Figure 42: South Asia Ibuprofen API Market Analysis by End User - 2022 & 2029

Figure 43: South Asia Ibuprofen API Market Y-o-Y Growth Projections by End User, 2022 - 2029

Figure 44: South Asia Ibuprofen API Market Attractiveness Analysis by End User, 2022 - 2029

Figure 45: East Asia Ibuprofen API Market Size (US$ Mn) Analysis, 2014-2021

Figure 46: East Asia Ibuprofen API Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 - 2029

Figure 47: East Asia Ibuprofen API Market Analysis by Country-2022 & 2029

Figure 48: East Asia Ibuprofen API Market Y-o-Y Growth Projections by Country, 2022 - 2029

Figure 49: East Asia Ibuprofen API Market Attractiveness Analysis by Country, 2022 - 2029

Figure 50: East Asia Ibuprofen API Market Analysis by End User - 2022 & 2029

Figure 51: East Asia Ibuprofen API Market Y-o-Y Growth Projections by End User, 2022 - 2029

Figure 52: East Asia Ibuprofen API Market Attractiveness Analysis by End User, 2022 - 2029

Figure 53: Oceania Ibuprofen API Market Size (US$ Mn) Analysis, 2014-2021

Figure 54: Oceania Ibuprofen API Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 - 2029

Figure 55: Oceania Ibuprofen API Market Analysis by Country -2022 & 2029

Figure 56: Oceania Ibuprofen API Market Y-o-Y Growth Projections by Country, 2022 - 2029

Figure 57: Oceania Ibuprofen API Market Attractiveness Analysis by Country, 2022 - 2029

Figure 58: Oceania Ibuprofen API Market Analysis by End User - 2022 & 2029

Figure 59: Oceania Ibuprofen API Market Y-o-Y Growth Projections by End User, 2022 - 2029

Figure 60: Oceania Ibuprofen API Market Attractiveness Analysis by End User, 2022 - 2029

Figure 61: MEA Ibuprofen API Market Size (US$ Mn) Analysis, 2014-2021

Figure 62: MEA Ibuprofen API Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 - 2029

Figure 63: MEA Ibuprofen API Market Analysis by Country - 2022 & 2029

Figure 64: MEA Ibuprofen API Market Y-o-Y Growth Projections by Country, 2022 - 2029

Figure 65: MEA Ibuprofen API Market Attractiveness Analysis by Country, 2022 - 2029

Figure 66: MEA Ibuprofen API Market Analysis by End User - 2022 & 2029

Figure 67: MEA Ibuprofen API Market Y-o-Y Growth Projections by End User, 2022 - 2029

Figure 68: MEA Ibuprofen API Market Attractiveness Analysis by End User, 2022 - 2029

Figure 69: China Ibuprofen API Market Size (US$ Mn) Analysis, 2014-2021

Figure 70: China Ibuprofen API Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 - 2029

Figure 71: China Ibuprofen API Market Analysis by End User - 2022 & 2029

Figure 72: China Ibuprofen API Market Y-o-Y Growth Projections by End User, 2022 - 2029

Figure 73: China Ibuprofen API Market Attractiveness Analysis by End User, 2022 - 2029

Figure 74: India Ibuprofen API Market Size (US$ Mn) Analysis, 2014-2021

Figure 75: India Ibuprofen API Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 - 2029

Figure 76: India Ibuprofen API Market Analysis by End User - 2022 & 2029

Figure 77: India Ibuprofen API Market Y-o-Y Growth Projections by End User, 2022 - 2029

Figure 78: India Ibuprofen API Market Attractiveness Analysis by End User, 2022 - 2029

Figure 79: Brazil Ibuprofen API Market Size (US$ Mn) Analysis, 2014-2021

Figure 80: Brazil Ibuprofen API Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 - 2029

Figure 81: Brazil Ibuprofen API Market Analysis by End User - 2022 & 2029

Figure 82: Brazil Ibuprofen API Market Y-o-Y Growth Projections by End User, 2022 - 2029

Figure 83: Brazil Ibuprofen API Market Attractiveness Analysis by End User, 2022 - 2029

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Pain Management Devices Market

Published : February 2022

Healthcare

Farm Animal Drugs Market

Published : July 2017

Healthcare

Analgesics Market

Published : December 2021

Healthcare

Branded Generics Market

Published : August 2021

Google translate